Nobody Tells You What GLP-1s Do to Your Sex Drive | GLS #213
Dr. Gabrielle LyonPublished on June 25, 2026
Summary authored by editor@wellifi.com
TLDR Summary
GLP-1 drugs, such as Ozempic and Mounjaro, may negatively impact sexual health in women while potentially improving sexual function in men. The lack of research on women's sexual health effects highlights the need for more comprehensive studies and open discussions with healthcare providers.
Key Points
- GLP-1 drugs like Ozempic and Mounjaro may have negative effects on sexual health in women.
- Women make up a significant percentage of GLP-1 drug users, but there is a lack of research on their sexual health effects.
- Men may experience improved sexual function while using GLP-1 drugs, showcasing differing effects based on gender.
- Open discussions with healthcare providers are crucial for identifying and addressing potential sexual side effects.
The Impact of GLP-1 Drugs on Sexual Health: What You Need to Know
In recent discussions surrounding GLP-1 receptor agonists, a class of medications primarily used for weight loss and diabetes management, another less-discussed aspect has emerged: their potential impact on sexual health, particularly in women. This article delves into the complexities of how GLP-1 drugs may affect sexual function, highlighting both sides of the argument.
Understanding GLP-1 Receptor Agonists
GLP-1 (glucagon-like peptide-1) receptor agonists, including medications like Ozempic (semaglutide) and Mounjaro (tirzepatide), are designed to regulate appetite and improve metabolic health. However, emerging evidence suggests that while these drugs can be beneficial for weight loss and blood sugar control in some populations, they may inadvertently cause sexual side effects, especially in women.
The Case Against GLP-1 Drugs and Sexual Health
The concern surrounding these drugs and sexual health primarily stems from reports that suggest they may diminish sexual desire and function in women. Here’s a closer look at the arguments:
Reported Side Effects
- Studies indicate that women are 60-70% of GLP-1 drug users, yet there is a glaring lack of evidence regarding their impact on female sexual health.
- Adverse effects related to sexual health are significantly underreported, with the FDA's reporting system capturing only a fraction of actual side effects.
- In clinical observations, women have reported decreased interest in sex and difficulty achieving orgasm after starting these medications.
Biological Mechanisms at Play
The mechanisms through which GLP-1 drugs might affect sexual function include:
- Activation of GLP-1 receptors in the brain, which can dampen the reward circuitry associated with pleasure, including sexual arousal.
- Potential tightening of blood vessels in genital tissues, which can hinder blood flow necessary for sexual arousal.
- Increased levels of sex hormone-binding globulin (SHBG) due to rapid weight loss, reducing the availability of free testosterone, crucial for sexual function.
The Case for GLP-1 Drugs and Sexual Health
Despite the concerns, there are arguments suggesting that GLP-1 drugs may not negatively impact sexual health or could even be beneficial in certain contexts:
Positive Outcomes in Men
- Research shows that men taking GLP-1 medications for obesity often experience improvements in testosterone levels and erectile function.
- In some studies, men on GLP-1 drugs reported less incidence of erectile dysfunction compared to those not receiving treatment.
Research Limitations
Critics of the negative view point out:
- Many studies on side effects rely on billing codes or voluntary reporting, which may not accurately reflect the experiences of all users.
- In clinical trials, men with obesity demonstrated improved sexual function metrics when properly tested.
Key Takeaways
- GLP-1 drugs are increasingly utilized for weight loss and diabetes management, but their effects on sexual health remain inadequately studied.
- Women may experience sexual side effects linked to these medications, yet comprehensive studies on female sexual function related to GLP-1 drugs are lacking.
- Men taking GLP-1 medications may see improvements in testosterone and sexual function, indicating a divergence in outcomes based on gender.
- Open conversations with healthcare providers are essential for addressing potential side effects and exploring alternative options if necessary.
Conclusion
The discourse regarding GLP-1 drugs and their impact on sexual health is complex and ongoing. Women, who represent a significant portion of GLP-1 users, deserve more rigorous research to understand the implications of these medications on sexual function. As we continue to explore the balance between metabolic health and sexual well-being, it’s crucial to advocate for comprehensive assessments that include sexual function as part of routine evaluations for those starting on these medications.
Ultimately, whether GLP-1 drugs are beneficial or detrimental to sexual health may depend significantly on individual patient characteristics and contexts. If you are considering or currently using a GLP-1 drug, engage in a dialogue with your healthcare provider about your sexual health and any concerns you may have.